Ingalla, Ellen Q.
15  Ergebnisse:
Personensuche X
?
1

Post-transcriptional Mechanisms Contribute to the Suppressi..:

Ingalla, Ellen Q. ; Miller, Jamie K. ; Wald, Jessica H....
Journal of Biological Chemistry.  285 (2010)  37 - p. 28691-28697 , 2010
 
?
4

GDC-9545 (Giredestrant): A Potent and Orally Bioavailable S..:

Liang, Jun ; Zbieg, Jason R. ; Blake, Robert A....
Journal of Medicinal Chemistry.  64 (2021)  16 - p. 11841-11856 , 2021
 
?
5

Discovery of GNE-149 as a Full Antagonist and Efficient Deg..:

Liang, Jun ; Blake, Robert ; Chang, Jae...
ACS Medicinal Chemistry Letters.  11 (2020)  6 - p. 1342-1347 , 2020
 
?
6

Unexpected equivalent potency of a constrained chromene ena..:

Zhang, Birong ; Kiefer, James R. ; Blake, Robert A....
Bioorganic & Medicinal Chemistry Letters.  29 (2019)  7 - p. 905-911 , 2019
 
?
 
?
8

Physiologically‐based pharmacokinetic/pharmacodynamic model..:

Ganti, Anjani ; Yu, Sijia ; Sharpnack, Danielle..
Biopharmaceutics & Drug Disposition.  44 (2023)  4 - p. 301-314 , 2023
 
?
 
?
13

The Leucine-rich Repeat Protein LRIG1 Is a Negative Regulat..:

Laederich, Melanie B. ; Funes-Duran, Melanie ; Yen, Lily...
Journal of Biological Chemistry.  279 (2004)  45 - p. 47050-47056 , 2004
 
?
14

Discovery of GNE-502 as an orally bioavailable and potent d..:

Zbieg, Jason R. ; Liang, Jun ; Li, Jun...
Bioorganic & Medicinal Chemistry Letters.  50 (2021)  - p. 128335 , 2021
 
?
15

Antibody-mediated delivery of chimeric protein degraders wh..:

Dragovich, Peter S. ; Adhikari, Pragya ; Blake, Robert A....
Bioorganic & Medicinal Chemistry Letters.  30 (2020)  4 - p. 126907 , 2020
 
1-15